Can a digital coach improve life for autistic young adults?

NCT ID NCT07533331

Recruiting now Symptom relief Sponsor: Friendi.fi Corporation Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This pilot study tests a digital coaching program for autistic young adults aged 18 to 35. The program uses two conversational agents to deliver personalized goal-setting and support based on a proven model called COMPASS. Over 10 weeks, 38 participants will use the app to work on their own goals, and researchers will measure changes in mental health and goal achievement.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: self-directed goal coaching (COMPASS + Goal Attainment Scaling) delivered via a digital platform with conversational agents
What this could lead to: If it works, this could provide a scalable, personalized support system to improve mental health and life outcomes for autistic young adults.
What could go wrong: This is a small pilot trial with only 38 participants and no control group, so results may not be generalizable. The intervention is behavioral and may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autism autism spectrum disorder Psychological Well-Being

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AUTISM

Contacts and locations

Locations

Ball State University
RECRUITING

Muncie, Indiana, 47306, United States
Indiana Institute on Disability and Community
RECRUITING

Bloomington, Indiana, 47408, United States
Norton Children's Autism Center502-588-0736 x 50608
RECRUITING

Louisville, Kentucky, 40202, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.